ArticleAccounts of chemical research2025
Activation of Molecular Oxygen and Selective Oxidation with Metal Complexes.
Article in Accounts of chemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Carboxylate-Ligand-Based Coordination Polymers and Metal Complexes: From Structural Diversity and Supramolecular Descriptors to Function-Oriented Design.Molecules (Basel, Switzerland) · 2026Review
- Catalytic conversion of methane to methanol: recent advances in MOF-based catalysts, oxidant strategies, and process optimization.RSC advances · 2026Review
- 3d Transition Metals-Catalyzed Electrooxidative and Photoredox Asymmetric CH Activation: A Sustainable Futuristic Prospective.Chemical record (New York, N.Y.) · 2026Review
- Elucidating the Oxygen-Activation Mechanism in Nonheme MnInorganic chemistry · 2026Article
- A mononuclear nonheme iron complex with higher affinity for ONature communications · 2026Article
- Evolution of Methods for the Oxidation of Primary Alcohols to Carboxylic Acids: From Metal Oxides to Biocatalysis.JACS Au · 2026Review
- Homogeneous copper-catalyzed aerobic oxidation of alcohols and aldehydes: mechanistic insights and recent advances.Beilstein journal of organic chemistry · 2026Review
- Strategic drive toward bi-linker MOFs: an efficient electrocatalyst for hydrogen and oxygen evolution reactions.RSC advances · 2025Article
- Mechanistic Insights into the Reductive N-O Bond Cleavage ofACS organic & inorganic Au · 2025Article
- Transformation of a PdChemical science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ConspectusSelective oxidation with molecular oxygen is one of the most appealing approaches to functionalization of organic molecules and, yet at the same time, one of the most challenging reactions facing organic synthesis due to poor selectivity control. Molecular oxygen is a green and inexpensive oxidant, producing water as the only byproduct in oxidation. Not surprisingly, it has been used in the manufacturing of many commodity chemicals in the industry. It is also nature's choice of oxidant and drives a variety of oxidation reactions critical to life and various other biologic processes. While the past decades have witnessed great progress in understanding, both structurally and mechanistically, how nature exploits metalloenzymes, i.e., monooxygenases and dioxygenases, to tackle some of the most challenging oxidation reactions, e.g., methane oxidation to methanol, there are only a small number of well-defined, man-made metal complexes that have been reported to enable selective oxidation with molecular oxygen of compounds more relevant to fine chemical and pharmaceutical synthesis.In the past 10 years or so, our laboratories have developed several transition metal complexes and shown that they are capable of catalyzing selective oxidation under 1 atm of O
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.